BREAST RECONSTRUCTION MARKET ANALYSIS

Breast cancer is a common disease in women and is mainly characterized by the formation of lumps in the breast, inverted nipples, fluid discharge from nipples, and change in breast shape. Breast reconstruction is a treatment for breast cancer, which includes creation of new breast shape structure through surgical procedure. This surgical process includes two main techniques: implant reconstruction and flap reconstruction. Silicone breast implants and saline breast implants are used in the implant reconstruction process. In the flap reconstruction process, breast-shaped structures are created by using tissues from the patient’s body such as the lower abdomen.

Breast Reconstruction Market Drivers

Development and adoption of advanced technologies for breast reconstruction is expected to drive the breast reconstruction market growth. For instance, in March 2016, the breast surgery and reconstructive team at the Valley Health Hospital in Ridgewood, New Jersey (U.S.) used pre-pectoral tissue expander placement technology, which is used for the treatment of breast cancer. Pre-pectoral tissue expander placement technology offers rapid recovery time, improved mobility time, and diminished post-operative pain for patient.

Furthermore, in September 2018, MTF Biologics expanded its portfolio products for breast reconstruction with the launch of Acellular Dermal Matrix (ADM), which is specially designed for pre-pectoral breast reconstruction procedures such as FlexHD Pliable PRE.

Breast Reconstruction Market Restraints

A major restraining factor which may hamper the breast reconstruction market size is product recall. For instance, in March 2019, Mentor Worldwide LLC and Sientra, Inc. received warning letters from the U.S. Food and drug Administration (FDA). These companies had not conducted the post-approval long-term safety and efficacy studies, which are required for the approval of the breast reconstruction implants. Mentor Worldwide LLC received recall for Memory Shape, Memory Gel, Spectrum silicone breast implants and saline implants, whereas Sientra, Inc. received recall for Opus silicone breast implants.

Breast Reconstruction Market Regional Analysis

On the basis of region, the global breast reconstruction market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

North America is expected to dominate in terms of breast reconstruction market share, owing to increasing awareness of breast cancer in the region. For instance, in November 2018, breast reconstruction awareness program was conducted in the Windsor Regional Hospital, Canada, with the special purpose to help and educate local women regarding breast cancer and breast reconstruction.

Furthermore, Asia Pacific is also projected to witness significant growth in the global breast reconstruction market, owing to increasing government initiatives regarding breast cancer treatment. For instance, in February 2018, the state health department of Tamil Nadu, India launched free cosmetic surgery clinic at the Government Stanley Medical College and Hospital, which offers free breast reconstruction surgery, as well as breast augmentation and breast reduction surgeries for those people who are below the poverty line.

Key players operating in the breast reconstruction market include, Polytech Health & Aesthetics GmbH, Allergan, Mentor Worldwide LLC (Johnson & Johnson), Sientra Inc., GC Aesthetics, RTI Surgical, Inc., Groupe Sebbin SAS, Integra LifeSciences, and Wanhe.   

Breast Reconstruction Market Taxonomy

By Product Type:

• Breast Implants
  • Silicone Breast Implants
  • Saline Breast Implants
• Tissue Expanders
• Acellular Dermal Matrix

By Shape:

• Round
• Anatomical

By End User:

• Hospitals and Clinics
• Ambulatory Surgical Centers
• Cosmetic Surgical Centers
• Others

By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East
• Africa